Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
524824:BOM
Bal Pharma Ltd
₹76.90
+1.13%
(+0.86) 1D
Apr 29, 1:23:26 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524824...
Open
₹77.50
High
₹77.50
Low
₹75.60
Mkt. cap
1.21B
Avg. vol.
2.69K
Volume
550.00
Dividend
1.56%
Quarterly dividend
₹0.30
Ex dividend date
Sep 18, 2025
P/E ratio
15.41
52-wk high
₹112.97
52-wk low
₹59.69
EPS
₹4.99
Shares outstanding
14.17M
No. of employees
986
News stories
From sources across the web
About Bal Pharma Ltd
CEO-
Employees986
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
818.76M
658.71M
740.25M
876.90M
Cost of goods sold
439.73M
335.43M
399.35M
461.60M
Cost of revenue
439.73M
335.43M
399.35M
461.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154.91M
148.04M
162.71M
173.24M
Operating expense
324.43M
287.89M
306.30M
352.15M
Total operating expenses
764.16M
623.31M
705.66M
813.74M
Operating income
54.60M
35.40M
34.59M
63.15M
Other non operating income
23.83M
7.22M
11.16M
3.26M
EBT including unusual items
38.94M
2.08M
7.17M
17.91M
EBT excluding unusual items
38.94M
2.08M
7.17M
17.91M
Income tax expense
-28.25M
-
-
-
Effective tax rate
-72.56%
-
-
-
Other operating expenses
147.72M
114.64M
120.88M
146.61M
Net income
67.34M
2.01M
7.10M
17.80M
Net profit margin
8.22%
0.30%
0.96%
2.03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-39.50M
-40.53M
-38.58M
-48.51M
Net interest expenses
-39.50M
-40.53M
-38.58M
-48.51M
Depreciation and amortization charges
21.80M
25.20M
22.71M
32.30M
EBITDA
79.03M
59.82M
58.55M
77.54M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more